Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: A meta-analysis

International Journal of Immunogenetics

Volumn 38, Issue 4, 2011, Pages 311-320

  Wang, J ^a   Cao, C ^b   Luo, H ^a   Xiong, S ^a   Xu, Y ^a   Xiong, W ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; COMPARATIVE STUDY; DISEASE ASSOCIATION; DOMINANT GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER;

ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959966008     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2011.01014.x     Document Type: Article

References (45)

1. Abraham, L.J. & Kroeger, K.M. (1999) Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. Journal of Leukocyte Biology, 66, 562.
2. Azmy, I.A., Balasubramanian, S.P., Wilson, A.G., Stephenson, T.J., Cox, A., Brown, N.J. & Reed, M.W (2004) Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Research, 6, R395.
3. Balkwill, F. (2002) Tumor necrosis factor or tumor promoting factor? Cytokine & Growth Factor Reviews, 13, 135.
4. Bazzoni, F. & Beutler, B. (1996) The tumor necrosis factor ligand and receptor families. New England Journal of Medicine, 334, 1717.
5. Brinkman, B.M.N., Zuijdgeest, D., Kaijzel, E.L., Breedveld, F.C. & Verweij, C.L. (1996) Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. Journal of Inflammation, 46, 32.
6. Chouchane, L., Ahmed, S.B., Baccouche, S. & Remadi, S. (1997) Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer, 80, 1489.
7. Colakogullari, M., Ulukaya, E., Yilmaztepe Oral, A., Aymak, F., Basturk, B., Ursavas, A. & Oral, H.B. (2008) The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochemistry Function, 26, 283.
8. Danforth, K.N., Rodriguez, C., Hayes, R.B., Sakoda, L.C., Huang, W.Y., Yu, K., et al. (2008) TNF polymorphisms and prostate cancer risk. Prostate, 68, 400.
9. Dunham, I., Sargent, C.A., Trowsdale, J. & Campbell, R.D. (1987) Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proceedings of the National Academy of Sciences of the United States of America, 84, 7237.
10. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629.
11. Fei, B.Y., Lv, H.X., Chen, Y.W. & Yang, J.M. (2005) TNF and IL-1 gene polymorphisms in colorectal cancer. Zhonghua Xiao Hua Za Zhi, 25, 681.
12. Flego, V., Radojcic Badovinac, A., Bulat-Kardum, L., Matanic, D., Crnic-Martinovic, M., Kapovic, M. & Ristic, S. (2009) Primary lung cancer and TNF-alpha gene polymorphisms: a case-control study in a Croatian population. Medical Science Monitor, 15, CR361.
13. Fujiki, H. & Suganuma, M. (1994) Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid. Journal of Biochemistry (Tokyo), 115, 1.
14. Gaudet, M.M., Egan, K.M., Lissowska, J., Newcomb, P.A., Brinton, L.A., Titus-Ernstoff, L., et al. (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Human Genetics, 121, 483.
15. Gorouhi, F., Islami, F., Bahrami, H. & Kamangar, F. (2008) Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. British Journal of Cancer, 98, 1443.
16. Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. (2003) Measuring inconsistency in meta-analyses. British Medical Journal, 327, 557.
17. Jang, W.H., Yang, Y.I., Yea, S.S., Lee, Y.J., Chun, J.H., Kim, H.I., Kim, M.S. & Paik, K.H. (2001) The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Letter, 166, 41.
18. de Jong, M.M., Nolte, I.M., te Meerman, G.J., van der Graaf, W.T., de Vries, E.G., Sijmons, R.H., Hofstra, R.M. & Kleibeuker, J.H. (2002) Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiology Biomarkers and Prevention, 11, 1332.
19. Kamali-Sarvestani, E., Merat, A. & Talei, A.R. (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Letter, 223, 113.
20. Kesarwani, P., Mandhani, A. & Mittal, R.D. (2009) Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort. Journal of Urology, 182, 2938.
21. Kohaar, I., Tiwari, P., Kumar, R., Nasare, V., Thakur, N., Das, B.C. & Bharadwaj, M. (2009) Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Research and Treatment, 114, 347.
22. Komori, A., Yatsunami, J., Suganuma, M., Okabe, S., Abe, S., Sakai, A., Sasaki, K. & Fujiki, H. (1993) Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformations. Cancer Research, 53, 1982.
23. Kroeger, K.M., Carville, K.S. & Abraham, L.J. (1997) The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Molecular Immunology, 34, 391.
24. Leek, R.D., Landers, R., Fox, S.B., Ng, F., Harris, A.L. & Lewis, C.E. (1998) Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. British Journal of Cancer, 77, 2246.
25. Macarthur, M., Sharp, L., Hold, G.L., Little, J. & El-Omar, E.M. (2005) The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiology Biomarkers & Prevention, 14, 1613.
26. MARIE-GENICA. (2010) Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Research and Treatment, 120, 727.
27. Mestiri, S., Bouaouina, N., Ahmed, S.B., Khedhaier, A., Jrad, B.B., Remadi, S. & Chouchane, L. (2001) Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer, 91, 672.
28. Moore, S.C., Leitzmann, M.F., Albanes, D., Weinstein, S.J., Snyder, K., Virtamo, J., et al. (2009) Adipokine genes and prostate cancer risk. International Journal of Cancer, 124, 869.
29. Park, K.S., Mok, J.W., Rho, S.A. & Kim, J.C. (1998) Analysis of TNFB and TNFA NcoI RFLP in colorectal cancer. Molecules and Cells, 8, 246.
30. Scola, L., Vaglica, M., Crivello, A., Palmeri, L., Forte, G.I., Macaluso, M.C., et al. (2006) Cytokine gene polymorphisms and breast cancer susceptibility. Annals New York Academy of Sciences, 1089, 104.
31. Seifart, C., Plagens, A., Dempfle, A., Clostermann, U., Vogelmeier, C., von Wichert, P. & Seifart, U. (2005) TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Disease Markers, 21, 157.
32. Shih, C.M., Lee, Y.L., Chiou, H.L., Chen, W., Chang, G.C., Chou, M.C. & Lin, L.Y. (2006) Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer, 52, 15.
33. Smith, K.C., Bateman, A.C., Fussell, H.M. & Howell, W.M. (2004) Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. European Journal of Immunogenetics, 31, 167.
34. Stankovic, M.M., Nestorovic, A.R., Tomovic, A.M., Petrovic-Stanojevic, N.D., Andjelic-Jelic, M.S., Dopudja-Pantic, V.B., Nagorni-Obradovic, L.M., Mitic-Milikic, M.M. & Radojkovic, D.P. (2009) TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma, 56, 348.
35. Suchy, J., Klujszo-Grabowska, E., Kladny, J., Cybulski, C., Wokolorczyk, D., Szymanska-Pasternak, J., Kurzawski, G., Scott, R.J. & Lubinski, J. (2008) Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer, 8, 112.
36. Toth, E.K., Kocsis, J., Madaras, B., Biro, A., Pocsai, Z., Fust, G., Blasko, B., Karadi, I., Adany, R. & Laki, J. (2007) The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. International Journal of Cancer, 121, 1744.
37. Tsilidis, K.K., Helzlsouer, K.J., Smith, M.W., Grinberg, V., Hoffman-Bolton, J., Clipp, S.L., Visvanathan, K. & Platz, E.A. (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes and Control, 20, 1739.
38. Uglialoro, A.M., Turbay, D., Pesavento, P.A., Delgado, J.C., McKenzie, F.E., Gribben, J.G., Hartl, D., Yunis, E.J. & Goldfeld, A.E. (1998) Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens, 52, 359.
39. Wan, C.P. & Ma, Z.M.. (2009) A study on the relationship between tumor necrosis factor-alpha gene promoter polymorphism and the susceptibility to the development of lung cancer. Lin Chuang Fei Ke Za Zhi, 14, 1000.
40. Wang, A.Z., Zhu, Z.Z., Jia, H.R., Jin, X.X., He, X.L. & Zhu, G.S. (2008) Association of TNF gene polymorphism with colorectal cancer risk. Tongji Da Xue Xue Bao (Medical Science), 29, 24.
41. Wang, M.H., Helzlsouer, K.J., Smith, M.W., Hoffman-Bolton, J.A., Clipp, S.L. & Grinberg, V. et al. (2009) Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate, 69, 874.
42. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. & Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 3195.
43. Wu, H.C., Chang, C.H., Chen, H.Y., Tsai, F.J., Tsai, J.J. & Chen, W.C. (2004) p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urologia Internationalis, 73, 41.
44. Wu, G.Y., Wang, X.M., Keese, M., Hasenberg, T. & Sturm, J.W. (2008) Association between tumor necrosis factor alpha gene polymorphism and colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 11, 569.
45. Zabaleta, J., Lin, H.Y., Sierra, R.A., Hall, M.C., Clark, P.E., Sartor, O.A., Hu, J.J. & Ochoa, A.C. (2008) Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis, 29, 573.